恒瑞医药：关于药品上市许可申请获受理的提示性公告

Core Viewpoint - Heng Rui Medicine has received acceptance from the National Medical Products Administration for its application for the marketing authorization of Sulfate Emamectin Tablets [1] Group 1 - The company announced on the evening of November 24 that it has received the acceptance notice from the National Medical Products Administration [1] - The application for the marketing authorization of Sulfate Emamectin Tablets has been officially accepted [1]